Safety and effectiveness of a somatropin biosimilar in children requiring growth hormone treatment: second analysis of the PATRO Children study Italian cohort
ConclusionsIn this sub-analysis of PATRO Children, Omnitrope® appeared to have acceptable safety and effectiveness in the treatment of in Italian children, which was consistent with the earlier findings from controlled clinical trials.
Source: Journal of Endocrinological Investigation - Category: Endocrinology Source Type: research
More News: Children | Clinical Trials | Diabetes | Diabetes Type 1 | Diabetes Type 2 | Endocrinology | Headache | Hormones | Insulin | Italy Health | Migraine | Nutropin AQ | Pain | Study